» Articles » PMID: 24082456

Association Between Urinary IgG and Relative Risk for Factors Affecting Proteinuria in Type 2 Diabetic Patients

Overview
Specialty Biochemistry
Date 2013 Oct 2
PMID 24082456
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Abnormal glomerular permeability is the primary step towards the glomerulosclerosis. The progression rate of glomerulosclerosis is proportionate to abundance and severity of lesions created at incipient stage, which is reflected as proteinuria even though eGFR remains in the normal range. Therefore, there is a current need to find out the association between relative risks for the factors leading to proteinuria. The relations could be more informative, if it is with respect to the macromolecules like "IgG" excretion in urine. Type 2 diabetic patients were selected for this study with eGFR > 75 ml/min/1.73 m(2) and grouped into four quartiles based on UIgGCR. The markers of key factors affecting progression of proteinuria were estimated through biochemical tests. The impact of these markers on proteinuria was accessed by applying multinomial logistic regression. The adjusted odds ratio for the UGAGCR was 1.186 (95 % CI: 1.061-1.327) P < 0.003 in highest quartiles of UIgGCR, followed by odds ratio for markers of collagen catabolism 1.051 (95 % CI: 1.025-1.079) P < 0.001, and USACR 1.044 (95 % CI: 1.013-1.077) P < 0.006 respectively. The marker of glycation, i.e., glycated hemoglobin showed the highest odds ratio 5.449 (95 % CI: 1.132-26.236) P < 0.035. In addition, odds for the systolic blood pressure was observed 1.387 (95 % CI: 1.124-1.712) P < 0.002. The higher odds inform and could help to discriminate the diabetic patients with fast progressive diabetic nephropathy. The study describes critical relationship between the urinary excretion of IgG and factors leading to proteinuria in type 2 diabetic patients.

Citing Articles

Understanding Inter-Individual Variability in Monoclonal Antibody Disposition.

Thomas V, Balthasar J Antibodies (Basel). 2019; 8(4).

PMID: 31817205 PMC: 6963779. DOI: 10.3390/antib8040056.


Associations of urinary, glomerular, and tubular markers with the development of diabetic kidney disease in type 2 diabetes patients.

Jiang X, Zhang Q, Wang H, Cui X, Liu R J Clin Lab Anal. 2017; 32(1).

PMID: 28236320 PMC: 6817283. DOI: 10.1002/jcla.22191.


Effect of Type 2 Diabetes Mellitus and Diabetic Nephropathy on IgG Pharmacokinetics and Subcutaneous Bioavailability in the Rat.

Chadha G, Morris M AAPS J. 2015; 17(4):965-75.

PMID: 25924888 PMC: 4477001. DOI: 10.1208/s12248-015-9771-3.

References
1.
Danziger J . Importance of low-grade albuminuria. Mayo Clin Proc. 2008; 83(7):806-12. DOI: 10.4065/83.7.806. View

2.
Dave G, Kalia K . Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy. Cell Mol Biol (Noisy-le-grand). 2007; 53(5):68-78. View

3.
De Jong J, Wevers R, Laarakkers C, Poorthuis B . Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses. Clin Chem. 1989; 35(7):1472-7. View

4.
MEILMAN E, URIVETZKY M, RAPOPORT C . Urinary hydroxyproline peptides. J Clin Invest. 1963; 42:40-50. PMC: 289248. DOI: 10.1172/JCI104694. View

5.
Chandalia H, Sadikot S, Bhargav D, Krishnaswamy P . Estimation of glycosylated hemoglobins by a simple chemical method and its use in monitoring control of diabetes mellitus. J Assoc Physicians India. 1980; 28(9):285-6. View